Trial record 4 of 5 for:
Insilico Medicine
A Phase 1, Evaluate the Safety, Tolerability, and Pharmacokinetics of INS018_055 in Healthy Subjects
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT05154240 |
Recruitment Status :
Completed
First Posted : December 13, 2021
Last Update Posted : June 29, 2023
|
Sponsor:
InSilico Medicine Hong Kong Limited
Information provided by (Responsible Party):
InSilico Medicine Hong Kong Limited
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Completed |
---|---|
Actual Primary Completion Date : | December 2, 2022 |
Actual Study Completion Date : | December 2, 2022 |